Optimal treatment options for patients with rectal cancer and low risk of progression

Objective. To determine the optimal indications for various treatment options in patients with low-risk rectal cancer depending on local invasion and negative prognostic factors. Material and methods. The study included 227 patients with T1—2N0M0 and T3aN0M0 rectal cancer. Fifty-two (22.9%) ones underwent surgical treatment alone, 81 (35.7%) — neoadjuvant radiotherapy alone, 94 (41.4%) — neoadjuvant irradiation with polyradiomodification. Radiotherapy was administered over five days (single focal dose 5 Gy, total focal dose 25 Gy). The second treatment option included irradiation and polyradiomodification: local microwave hyperthermia, intrarectal administration of biopolymer composition with metronidazole, and oral administration of Capecitabine at a daily dose of 2.0 g/m2 for 2 weeks. Surgery was performed 6—8 weeks after irradiation. Results. For T1sm1—2N0M0 rectal cancer, surgical treatment is indicated, including transanal endoscopic surgery or rectal resection. Radiotherapy is not necessary. In T1sm3—T2N0M0 rectal cancer, recurrence rate after surgical treatment was 6.4% (3 out of 47) and did not differ from recurrence rate (6.5%, 2 out of 31) after neoadjuvant irradiation alone. There were no recurrences in 24 patients after polyradiomodification. Neoadjuvant irradiation alone is ineffective for T3aN0M0 rectal cancer. Recurrences were detected in 2 (4.9%) out of 49 patients. Only polyradiomodification was able to improve treatment outcomes. None out of 94 patients had recurrences, and 88.3% of them underwent sphincter-sparing treatment. Conclusion. Optimal treatment option for patients with low risk of progression is determined by local tumor spread. Polyradiomodification ensures high local control and maximum preservation of the affected organ.

Authors

Institutions

Publication Details

Journal
Pirogov Russian Journal of Surgery
Published
2026-11-13
DOI
https://doi.org/10.17116/hirurgia202611140
Primary Topic
Colorectal Cancer Surgical Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Optimal treatment options for patients with rectal cancer and low risk of progression

В. А. Алиев, Олег Александрович Власов, Yu. А. Barsukov, Заурбек Алиханович Дудаев et al.
Pirogov Russian Journal of Surgery
Colorectal Cancer Surgical Treatments
article

Optimal treatment options for patients with rectal cancer and low risk of progression

В. А. Алиев, Олег Александрович Власов, Yu. А. Barsukov, Заурбек Алиханович Дудаев, С. И. Ткачев, А. Г. Перевощиков
article en

Abstract

Objective. To determine the optimal indications for various treatment options in patients with low-risk rectal cancer depending on local invasion and negative prognostic factors. Material and methods. The study included 227 patients with T1—2N0M0 and T3aN0M0 rectal cancer. Fifty-two (22.9%) ones underwent surgical treatment alone, 81 (35.7%) — neoadjuvant radiotherapy alone, 94 (41.4%) — neoadjuvant irradiation with polyradiomodification. Radiotherapy was administered over five days (single focal dose 5 Gy, total focal dose 25 Gy). The second treatment option included irradiation and polyradiomodification: local microwave hyperthermia, intrarectal administration of biopolymer composition with metronidazole, and oral administration of Capecitabine at a daily dose of 2.0 g/m2 for 2 weeks. Surgery was performed 6—8 weeks after irradiation. Results. For T1sm1—2N0M0 rectal cancer, surgical treatment is indicated, including transanal endoscopic surgery or rectal resection. Radiotherapy is not necessary. In T1sm3—T2N0M0 rectal cancer, recurrence rate after surgical treatment was 6.4% (3 out of 47) and did not differ from recurrence rate (6.5%, 2 out of 31) after neoadjuvant irradiation alone. There were no recurrences in 24 patients after polyradiomodification. Neoadjuvant irradiation alone is ineffective for T3aN0M0 rectal cancer. Recurrences were detected in 2 (4.9%) out of 49 patients. Only polyradiomodification was able to improve treatment outcomes. None out of 94 patients had recurrences, and 88.3% of them underwent sphincter-sparing treatment. Conclusion. Optimal treatment option for patients with low risk of progression is determined by local tumor spread. Polyradiomodification ensures high local control and maximum preservation of the affected organ.

Pirogov Russian Journal of Surgery(11)
Moscow Clinical Scientific Center (RU), Russian Cancer Research Center NN Blokhin (RU), Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology (RU)
Colorectal Cancer Surgical Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon